Back
Ensysce Biosciences Vs. Relmada Therapeutics Industry Stock Comparison
Sell
20
ENSC
Ensysce Biosciences
Last Price:
0.56
Seasonality Move:
-25.08%
Sell
45
RLMD
Relmada Therapeutics
Last Price:
3.85
Seasonality Move:
-13.88%
Sell
20
Ensysce Biosciences (ENSC)
is a Sell
Is Ensysce Biosciences a Buy, Sell or Hold?
- The current Ensysce Biosciences [ENSC] share price is $0.56. The Score for ENSC is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- ENSC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
45
Relmada Therapeutics (RLMD)
is a Sell
Is Relmada Therapeutics a Buy, Sell or Hold?
- The current Relmada Therapeutics [RLMD] share price is $3.83. The Score for RLMD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- RLMD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ENSC Stock Price Chart
What is Ensysce Biosciences's stock price today?
-
The Ensysce Biosciences share price today is $0.56
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENSC is experiencing selling pressure, which indicates risk of future bearish movement.
RLMD Stock Price Chart
What is Relmada Therapeutics's stock price today?
-
The Relmada Therapeutics share price today is $3.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLMD is experiencing slight selling pressure.
ENSC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 33.67 | Sell |
| Chaikin Money Flow: | -47541 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.54 - 0.74) | Sell |
| Bollinger Bands (100): | (0.67 - 1.23) | Sell |
RLMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 40.68 | Sell |
| Chaikin Money Flow: | -10730 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.71 - 4.59) | Sell |
| Bollinger Bands (100): | (3.42 - 5.5) | Sell |
ENSC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.58 | Sell |
| 20-day SMA: | 0.6 | Sell |
| 50-day SMA: | 0.72 | Sell |
| 200-day SMA: | 1.19 | Sell |
| 8-day EMA: | 0.57 | Sell |
| 20-day EMA: | 0.61 | Sell |
| 50-day EMA: | 0.73 | Sell |
| 200-day EMA: | 8.36 | Sell |
RLMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.72 | Buy |
| 20-day SMA: | 4.01 | Sell |
| 50-day SMA: | 4.8 | Sell |
| 200-day SMA: | 3.72 | Buy |
| 8-day EMA: | 3.8 | Buy |
| 20-day EMA: | 4.01 | Sell |
| 50-day EMA: | 4.38 | Sell |
| 200-day EMA: | 4.42 | Sell |
Ensysce Biosciences Earnings Growth & ENSC Earnings Dates
- Analysts estimate an earnings increase this quarter of $5.03 per share, an increase next quarter of $0.17 per share, an increase this year of $17.95 per share, and an increase next year of $1.37 per share.
Relmada Therapeutics Earnings Growth & RLMD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and an increase next year of $0.39 per share.
Ensysce Biosciences Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Relmada Therapeutics Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||